| Primary |
| Mineral Supplementation |
55.6% |
| Hypocalcaemia |
33.3% |
| Product Used For Unknown Indication |
11.1% |
|
| Administration Site Reaction |
8.3% |
| Application Site Discolouration |
8.3% |
| Application Site Erythema |
8.3% |
| Cardiac Arrest |
8.3% |
| Extravasation |
8.3% |
| Incorrect Dose Administered |
8.3% |
| Infusion Site Discolouration |
8.3% |
| Infusion Site Oedema |
8.3% |
| Medication Error |
8.3% |
| Overdose |
8.3% |
| Panic Attack |
8.3% |
| Vomiting |
8.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
35.8% |
| Product Used For Unknown Indication |
18.4% |
| Electrolyte Substitution Therapy |
6.9% |
| Pneumonia |
5.1% |
| Vascular Operation |
4.1% |
| Parenteral Nutrition |
3.5% |
| Hypotension |
3.4% |
| Stupor |
3.2% |
| Gastrointestinal Disorder |
3.1% |
| Arthritis |
2.9% |
| Hypertension |
2.2% |
| Pain |
2.2% |
| Restlessness |
1.5% |
| Body Temperature Decreased |
1.2% |
| Depression |
1.2% |
| Resuscitation |
1.2% |
| Hyperglycaemia |
1.1% |
| Hypothyroidism |
1.1% |
| Constipation |
0.9% |
| Polyuria |
0.9% |
|
| Toxic Epidermal Necrolysis |
25.4% |
| Rash Erythematous |
11.1% |
| Renal Failure Acute |
7.9% |
| Skin Necrosis |
6.3% |
| Vomiting |
6.3% |
| Stevens-johnson Syndrome |
4.8% |
| Anaphylactic Reaction |
3.2% |
| Intra-uterine Death |
3.2% |
| Medication Error |
3.2% |
| Overdose |
3.2% |
| Renal Failure |
3.2% |
| Somnolence |
3.2% |
| Therapeutic Agent Toxicity |
3.2% |
| Tremor |
3.2% |
| Ventricular Tachycardia |
3.2% |
| Weight Increased |
3.2% |
| Anaphylactic Shock |
1.6% |
| Anaphylactoid Shock |
1.6% |
| Blister |
1.6% |
| Cardiac Arrest |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
53.6% |
| Drug Use For Unknown Indication |
21.3% |
| Coronary Artery Bypass |
4.3% |
| Osteoporosis |
2.4% |
| Hypertension |
2.0% |
| Rheumatoid Arthritis |
1.8% |
| Pain |
1.8% |
| Prophylaxis |
1.8% |
| Aortic Valve Replacement |
1.4% |
| Adverse Event |
1.3% |
| Metastases To Bone |
1.1% |
| Catheterisation Cardiac |
1.1% |
| Sedation |
1.0% |
| Anxiety |
0.8% |
| Breast Cancer |
0.8% |
| Prostate Cancer |
0.8% |
| Acute Lymphocytic Leukaemia |
0.7% |
| Premedication |
0.7% |
| Mitral Valve Replacement |
0.6% |
| Insomnia |
0.6% |
|
| Pain |
12.8% |
| Injury |
11.2% |
| Vomiting |
7.7% |
| Fear |
7.2% |
| Weight Decreased |
7.0% |
| Unevaluable Event |
6.7% |
| Renal Impairment |
4.9% |
| Anxiety |
4.7% |
| Stress |
4.3% |
| Weight Increased |
4.3% |
| Emotional Distress |
4.1% |
| Anhedonia |
4.0% |
| Renal Failure |
3.2% |
| Pneumonia |
2.7% |
| Respiratory Failure |
2.7% |
| Urinary Tract Infection |
2.7% |
| Pyrexia |
2.5% |
| Tremor |
2.5% |
| Vision Blurred |
2.5% |
| Death |
2.3% |
|
| Interacting |
| Drug Use For Unknown Indication |
90.0% |
| Gastrooesophageal Reflux Disease |
10.0% |
|
| Insomnia |
50.0% |
| Vomiting |
50.0% |
|
